PRMT1 Antikörper (AA 20-353)

Produktnummer ABIN7165065

Produktdetails anti-PRMT1 Antikörper

Target: PRMT1 (Protein Arginine Methyltransferase 1 (PRMT1))

Bindungsspezifität: AA 20-353

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PRMT1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität: Human

Aufreinigung: Antigen Affinity Purified

Immunogen: Recombinant Human Protein arginine N-methyltransferase 1 protein (20-353AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu PRMT1

Target: PRMT1 (Protein Arginine Methyltransferase 1 (PRMT1))

Andere Bezeichnung: PRMT1 (PRMT1 Produkte)

Hintergrund:

Background: Arginine methyltransferase that methylates (mono and asymmetric dimethylation) the guanidino nitrogens of arginyl residues present in proteins such as ESR1, histone H2, H3 and H4, PIAS1, HNRNPA1, HNRNPD, NFATC2IP, SUPT5H, TAF15 and EWS. Constitutes the main enzyme that mediates monomethylation and asymmetric dimethylation of histone H4 \\\'Arg-4\\\' (H4R3me1 and H4R3me2a, respectively), a specific tag for epigenetic transcriptional activation. Together with dimethylated PIAS1, represses STAT1 transcriptional activity, in the late phase of interferon gamma (IFN-gamma) signaling. May be involved in the regulation of TAF15 transcriptional activity, act as an activator of estrogen receptor (ER)-mediated transactivation, play a key role in neurite outgrowth and act as a negative regulator of megakaryocytic differentiation, by modulating p38 MAPK pathway. Methylates FOXO1 and retains it in the nucleus increasing its transcriptional activity.

Aliases: ANM 1 antibody, ANM1 antibody, ANM1_HUMAN antibody, HCP 1 antibody, HCP1 antibody, Heterogeneous nuclear ribonucleoprotein methyltransferase 1 like 2 antibody, Heterogeneous nuclear ribonucleoproteins methyltransferase like 2 antibody, Heterogeneous nuclear ribonucleoproteins methyltransferase like2 antibody, Histone-arginine N-methyltransferase PRMT1 antibody, HMT 2 antibody, HMT1 (hnRNP methyltransferase S. cerevisiae) like 2 antibody, HMT1 hnRNP methyltransferase antibody, HMT1 hnRNP methyltransferase like 2 (S. cerevisiae) antibody, HMT1 hnRNP methyltransferase like 2 antibody, HMT2 antibody, HRMT1 L2 antibody, HRMT1L 2 antibody, HRMT1L2 antibody, Human mRNA for suppressor for yeast mutant antibody, Human mRNA for suppressor for yeast mutant complete cds antibody, Interferon receptor 1 bound protein 4 antibody, Interferon receptor 1 bound protein4 antibody, Interferon receptor 1-bound protein 4 antibody, Interferon receptor 1bound protein 4 antibody, IR1 B4 antibody, IR1B 4 antibody, IR1B4 antibody, Mrmt 1 antibody, Mrmt1 antibody, PRMT 1 antibody, PRMT1 antibody, Protein arginine methyltransferase 1 antibody, Protein arginine N methyltransferase 1 antibody, Protein arginine N methyltransferase1 antibody, Protein arginine N-methyltransferase 1 antibody, R1B4 antibody, S. cerevisiae like 2 antibody

UniProt: Q99873